Mark Strobeck

This profile gathers the share dealings of Mark Strobeck across 3 companies, led by Rockwell Medical, Inc., Egalet Corp and Windtree Therapeutics Inc. Between 31 December 2015 and 1 October 2026, the trades on record add up to 16 filings.

On the market, this insider has only sold: 8 sales, €43k in total. No amount is published for 1 filing, which the totals therefore leave out. Outside the open market, there are 8 share grants. Since January 2026: no purchases and 1 sale on the market.

The latest filing, published on 5 October 2026, reports an open-market sale of €7,427 in Rockwell Medical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.